[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2002, 28(2) 116-118 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
������ͷ������
ϸ������
����ø
���������������
����
���긻
PubMed
Article by
Article by

��Σ��������ͷ���������������ӻ���

����, ���긻

���пƼ���ѧͬ��ҽѧԺ����Э��ҽԺƤ����, �人430022

ժҪ��

��Σ��������ͷ������(16,18��)��Ⱦ�ѱ�֤ʵ�ɵ�����ֳϵͳ��Ƥ���Ϳ�ǻ�ȵĶ����������䡣���ŷ�������ѧ�����Ľ�һ����չ,����������ķ������Ƶ���ʶҲԽ��Խ���롣����ּ��ϸ�����ڵ�����ϸ������,���������ø,�������ݷ��ӻ��Ƶȼ�������������Σ��������ͷ���������������ӻ��ơ�

�ؼ����� ������ͷ������   ϸ������   ����ø  

Abstract:

Keywords:
�ո����� 2001-08-17 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Burk RD,Ho GY,Beardsley L,et al.Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women.J Infect Dis,1996,174(4):679-689.
[2] Evander M,Edlund K,Gustafsson A,et al.Human papillomavims infec-tion is transient in young women:a pepulation-based cohort study.J Infect Dis,1995,171 (4):1026-1030.
[3] Karlsson R,Jonsson M,Edhnd K,et al.Lifetime number of partners as the only independent risk factor for human papillomavirus infection:a population-based study.Sex Transm Dis,1995,22(2):119-127.
[4] Fairley CK,Chen S,Ugoni A,et al.Human papillomavirus infection and its relationship to recent and distant sexual partners.Obstet Gynecol,1994,84(5):755-759.
[5] de Villiers EM.Human pathogenic papillomavirus types:an update.Curt Top Microbiol Immunol,1994,186:1-12.
[6] zur Hansen H.Papillomaviroses causing cancer:evasion from host-cell control in early events in carcinogenesis.J Natl Cancer Inst,2000,92(9):690-698.
[7] Kjellberg L,Hallmans G,Ahren AM,et al.Smoking,diet,pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neo-plasia in relation to human papillomavirus infection.Br J Cancer,2000,82(7):1332-1338.
[8] Nurse P.A long twentieth century of the cell cycle and beyond.Cell,2000,100(1):71-78.
[9] Oda H,Kumar S,Howley PM.Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination.Proc Natl Acad Sci U S A,1999,96 (17):9557-9562.
[10] Kao WH,Beandenon SL,Talis AL,et al.Human papillomavims type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.J Virol,2000,74(14):6408-6417.
[11] Tortorella D,Gewurz BE,Furman MH,et al.Viral subversion of the im-mtme system.Annu Rev Immunol,2000,18:861-926.
[12] Crish JF,Bone F,Balasubramanian S,et al.Suprabasal expression of the human papillomavirus type 16 onceproteins in mouse epidermis alters expression of cell cycle regulatory proteins.Carcinogenesis,2000,21 (5):1031-1037.
[13] Duensing S,Lee LY,Duensing A,et al.The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cy-cle.Proc Natl Acad Sci U S A,2000,97(18):10002-10007.
[14] Duensing S,Duonsing A,Crum CP,et al.Human papillomavirus type 16 E7 onceprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.Cancer Res,2001,61(6):2356-2360.
[15] Oh ST,Kyo S,Laimins LA.Telomerase activation by human papillo-mavims type 16 E6 protein:induction of human telomerase reverse tran-scriptase expression through Myc and GC-rich Spl binding sites.J Virol,2001,75(12):5559-5566.
[16] Klingelhutz AJ,Foster SA,McDongall JK.Telomerase activation by the E6 gene product of human papillomavirus type 16.Nature,1996,380(6569):79-82.
[17] Chen TM,Pecoraro G,Defendi V.Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells.Cancer Res,1993,53(5):1167-1171.
[18] Massimi P,Banks L.Differential phosphorylation of the HPV-16 E7 oneo-protein during the cell cycle.Virology,2000,276(2):388-394.
[19] O'Connor MJ,Tan SH,Tan CH,et al.YY1 represses human papillo-mavirus type 16 transcription by quenching AP-1 activity.J Virol,1996,70(10):6529-6539.
[20] May M,Dong XP,Beyer-Finkler E,et al.The E6/E7 promoter of extra-chromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.EMBO J,1994,13(6):1460-1466.
[21] Bamard P,McMillan NA.The human papillomavirus E7 onceprotein abrogates signaling mediated by interferon-alpha.Virology,1999,259(2):305-313.
[22] Gondboum S,Didcock L,Randall RE.Interferons:cell signalling,immtme modulation,antiviral response and virus countermeasures.J Gen Viral,2000,81 (Pt 10):2341-2364.
[23] Ronce LV,Karpova AY,Vidal M,et al.Human papillomavirus 16 E6 on-coprotein binds to interferon regulatory factor-3 and inhibits its transcrip-tional activity.Genes Dev,1998,12(13):2061-2072.
[24] Noes M,Genghegan JM,Munson P,et al.Human papillomavims type 16 E6 and E7 proteins inhibit differentiation-dependent expression of trans-forming growth factor-beta2 in cervical keratinocytes.Cancer Res,2000,60(15):4289-4298.
�������������
1������ �̺�.����ͷ��������Ⱦ���ʸ�˹ϸ��Ӱ����Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2011,37(3): 174-176
2�������ұ���, �������У.��Ů������ͷ��������Ⱦ����ֳ������[J]. ����Ƥ���Բ�ѧ��־, 1995,21(3): 168-171
3����Ⱥ����, ��������У, ��������У.��ֳ��������ͷ��������Ⱦ������ѧ�о�[J]. ����Ƥ���Բ�ѧ��־, 1997,23(4): 219-222
4����־������, ���У.����ʪ�������ѧ�о���չ[J]. ����Ƥ���Բ�ѧ��־, 1998,24(3): 155-158
5���������, ֣ï����У.������ͷ��������ص�Ƥ����ճĤ����[J]. ����Ƥ���Բ�ѧ��־, 1998,24(6): 360-362
6���·�����, Ҷ��٫��У.������ͷ��������Ⱦ�ֲ�ϸ������ȱ�ݵ��γɻ���[J]. ����Ƥ���Բ�ѧ��־, 2001,27(3): 163-165
7�������, �Ŷ���, ������.����ʪ�෢���͸�����Σ�������о���״[J]. ����Ƥ���Բ�ѧ��־, 2002,28(5): 303-305

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־